BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27519177)

  • 1. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
    Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
    BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.
    Lin J; Gill A; Zahm SH; Carter CA; Shriver CD; Nations JA; Anderson WF; McGlynn KA; Zhu K
    Int J Cancer; 2017 Jul; 141(2):254-263. PubMed ID: 28380674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum.
    Wen-Xiu X; Xiao-Wei Z; Hai-Ying D; Ying-Hui T; Si-Si K; Xiao-Fang Z; Huang P
    Medicine (Baltimore); 2018 Dec; 97(51):e13652. PubMed ID: 30572481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes.
    Chen H; Yao W; Chu Q; Han R; Wang Y; Sun J; Wang D; Wang Y; Cao M; He Y
    Cancer Lett; 2015 Dec; 369(1):97-102. PubMed ID: 26341687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of small cell lung cancer patients with diabetes treated with metformin.
    Xu T; Liang G; Yang L; Zhang F
    Clin Transl Oncol; 2015 Oct; 17(10):819-24. PubMed ID: 26063645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes.
    Tan BX; Yao WX; Ge J; Peng XC; Du XB; Zhang R; Yao B; Xie K; Li LH; Dong H; Gao F; Zhao F; Hou JM; Su JM; Liu JY
    Cancer; 2011 Nov; 117(22):5103-11. PubMed ID: 21523768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
    Chuang MC; Yang YH; Tsai YH; Hsieh MJ; Lin YC; Lin CK; Chen PC; Yang TM
    PLoS One; 2018; 13(1):e0191129. PubMed ID: 29329345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
    Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
    Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
    Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM
    Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
    Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
    Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.
    Zeng S; Gan HX; Xu JX; Liu JY
    Med Clin (Barc); 2019 Apr; 152(8):291-297. PubMed ID: 30173870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting.
    Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B
    Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
    Deng Y; Wang J; Li W; Xiong W; Wang X
    J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
    Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with stage IV lung cancer with diabetes treated with metformin.
    Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP
    Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
    Wink KC; Belderbos JS; Dieleman EM; Rossi M; Rasch CR; Damhuis RA; Houben RM; Troost EG
    Radiother Oncol; 2016 Mar; 118(3):453-9. PubMed ID: 26861738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
    Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
    Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
    Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
    Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
    Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
    Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.